These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33039)

  • 21. Action of intermediate doses of methotrexate on dihydrofolate reductase in malignant diseases.
    Tzortzatou-Stathopoulou F; Zavitsa-Pateli H; Mousatos G; Prodromou N; Kairis M; Pappas J
    Pediatr Hematol Oncol; 1987; 4(1):43-53. PubMed ID: 3152912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dihydrofolate reductase from Neisseria sp.
    Averett DR; Roth B; Burchall JJ; Baccanari DP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):428-35. PubMed ID: 111611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydrofolate reductase from Eimeria tenella: rationalization of chemotherapeutic efficacy of pyrimethamine.
    Wang CC; Stotish RL; Poe M
    J Protozool; 1975 Nov; 22(4):564-8. PubMed ID: 1059772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydrofolate reductase and thymidylate synthetase in strains of Streptococcus faecium resistant to pyrimethamine, chlorguanide triazine, trimethoprim, and amethopterin.
    Freisheim JH; Smith CC; Guzy PM
    Arch Biochem Biophys; 1972 Jan; 148(1):1-9. PubMed ID: 5058682
    [No Abstract]   [Full Text] [Related]  

  • 25. [Inhibition of human leukocytes dihydrofolate reductase by triamterene and its metabolites (author's transl)].
    Schalhorn A; Wilmanns W
    Arzneimittelforschung; 1979; 29(9):1409-11. PubMed ID: 583251
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of Candida albicans dihydrofolate reductase.
    Baccanari DP; Tansik RL; Joyner SS; Fling ME; Smith PL; Freisheim JH
    J Biol Chem; 1989 Jan; 264(2):1100-7. PubMed ID: 2642898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.
    Barrow EW; Bourne PC; Barrow WW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4643-9. PubMed ID: 15561838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neisseriaceae, a group of bacteria with dihydrofolate reductases, moderately susceptible to trimethoprim.
    Then RL
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):450-8. PubMed ID: 44939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A histochemical study on the dihydrofolate reductase activity in leukemia.
    Onicescu D; Stoica I; Tasca L
    Acta Histochem; 1973; 45(2):214-8. PubMed ID: 4199687
    [No Abstract]   [Full Text] [Related]  

  • 30. Properties of a methotrexate-insensitive variant of dihydrofolate reductase derived from methotrexate-resistant L5178Y cells.
    Goldie JH; Dedhar S; Krystal G
    J Biol Chem; 1981 Nov; 256(22):11629-35. PubMed ID: 7298621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and properties of Escherichia coli dihydrofolate reductase.
    Baccanari D; Phillips A; Smith S; Sinski D; Burchall J
    Biochemistry; 1975 Dec; 14(24):5267-73. PubMed ID: 46
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia.
    Navarro-Martínez MD; Navarro-Perán E; Cabezas-Herrera J; Ruiz-Gómez J; García-Cánovas F; Rodríguez-López JN
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2914-20. PubMed ID: 15980368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory mutants of dihydrofolate reductase in Escherichia coli K12.
    Sheldon R; Brenner S
    Mol Gen Genet; 1976 Aug; 147(1):91-7. PubMed ID: 785230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. R-factor mediated dihydrofolate reductases which confer trimethoprim resistance.
    Amyes SG; Smith JT
    J Gen Microbiol; 1978 Aug; 107(2):263-71. PubMed ID: 29076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homology of Escherichia coli B glutathione synthetase with dihydrofolate reductase in amino acid sequence and substrate binding site.
    Kato H; Chihara M; Nishioka T; Murata K; Kimura A; Oda J
    J Biochem; 1987 Jan; 101(1):207-15. PubMed ID: 3553173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of folate antagonists on dihydrofolate reductase activity demonstrated cytochemically.
    Tzortzatou F; Hayhoe FG
    Br J Haematol; 1974 Oct; 28(2):209-16. PubMed ID: 4433479
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterisation of a new transposon-mediated trimethoprim-resistant dihydrofolate reductase.
    Young HK; Amyes SG
    Biochem Pharmacol; 1985 Dec; 34(24):4334-7. PubMed ID: 3000384
    [No Abstract]   [Full Text] [Related]  

  • 38. Dihydrofolate reductase. The stereochemistry of inhibitor selectivity.
    Matthews DA; Bolin JT; Burridge JM; Filman DJ; Volz KW; Kraut J
    J Biol Chem; 1985 Jan; 260(1):392-9. PubMed ID: 3880743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning, expression, and characterization of Mycobacterium tuberculosis dihydrofolate reductase.
    White EL; Ross LJ; Cunningham A; Escuyer V
    FEMS Microbiol Lett; 2004 Mar; 232(1):101-5. PubMed ID: 15019741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues.
    Stone SR; Morrison JF
    Biochim Biophys Acta; 1986 Feb; 869(3):275-85. PubMed ID: 3511964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.